COGSTATE LTD - Announcements

1.00%

$2.02

Market Cap $345.8M

Healthcare Biotechnology

Cogstate Limited is a neuroscience technology company optimizing brain health assessments... Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CGS	Appendix 3B		09/09/14	1.57MB	Share
CGS	Appendix 3B		01/09/14	1.61MB	Share
CGS	Cogstate Test Provides Better Assessment than Observation	PRICE SENSITIVE	25/08/14	268.71KB	Share
CGS	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	20/08/14	1.01MB	Share
CGS	Contracts signed since 1 July 2014 hit $9 million	PRICE SENSITIVE	14/08/14	271.16KB	Share
CGS	Appendix 3B		12/08/14	1.6MB	Share
CGS	Cogstate signs $7.3 million sales contract	PRICE SENSITIVE	05/08/14	280.96KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	22/07/14	1.58MB	Share
CGS	Appendix 3B		18/07/14	1.58MB	Share
CGS	Cogstate provides update on sales contracts	PRICE SENSITIVE	24/06/14	274.76KB	Share
CGS	Appendix 3B		18/06/14	1.58MB	Share
CGS	Cogstate signs first client to Precision Recruitment	PRICE SENSITIVE	12/06/14	267.7KB	Share
CGS	Investor Presentation		06/06/14	1.19MB	Share
CGS	Business update and guidance on FY14 results	PRICE SENSITIVE	06/06/14	280.62KB	Share
CGS	Cogstate announces updated agreement with Merck Canada	PRICE SENSITIVE	02/06/14	438.11KB	Share
CGS	Appendix 3B		07/05/14	1.59MB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/14	1.56MB	Share
CGS	Company Secretary Appointment/Resignation		28/04/14	282.41KB	Share
CGS	Cogstate technology chosen for major Phase III trial	PRICE SENSITIVE	24/03/14	363.19KB	Share
CGS	Change of Director's Interest Notice		26/02/14	308.47KB	Share
CGS	H1 FY14 Investor Presentation		19/02/14	1.3MB	Share
CGS	Business Update - Significant growth in future revenue	PRICE SENSITIVE	18/02/14	286.33KB	Share
CGS	Appendix 4D and Half-Year Financial Report	PRICE SENSITIVE	18/02/14	5.15MB	Share
CGS	Notification of 2014 Half Year Results		12/02/14	247.97KB	Share
CGS	Cogstate Test to be used in large paediatric clinical trial	PRICE SENSITIVE	12/02/14	244.69KB	Share
CGS	Change of Director's Interest Notice		29/01/14	298.1KB	Share
CGS	Appendix 3B		29/01/14	1.76MB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/14	1.49MB	Share
CGS	Appendix 3B		03/01/14	1.86MB	Share
CGS	Change in substantial holding		24/12/13	656.03KB	Share
CGS	Change in substantial holding		24/12/13	2.75MB	Share
CGS	Change of Director's Interest Notice		24/12/13	309.23KB	Share
CGS	Change of Director's Interest Notice		24/12/13	295.43KB	Share
CGS	Change of Director's Interest Notice		24/12/13	297.51KB	Share
CGS	Change of Director's Interest Notice		24/12/13	297.91KB	Share
CGS	Change of Director's Interest Notice		24/12/13	298.64KB	Share
CGS	Cogstate Entitlement Offer - Notice of Under-subscriptions		23/12/13	307.01KB	Share
CGS	Cogstate completes A$8m Capital Raising		23/12/13	245.53KB	Share
CGS	Appendix 3B		23/12/13	2.79MB	Share
CGS	Cogstate Awarded Tender	PRICE SENSITIVE	23/12/13	375.11KB	Share
CGS	Change of Director's Interest Notice		17/12/13	307.1KB	Share
CGS	Axon Sports Strategic Partnership with GSK Human Lab		03/12/13	406.75KB	Share
CGS	Rights Issue Offer Document	PRICE SENSITIVE	03/12/13	1.14MB	Share
CGS	Change of Director's Interest Notice		02/12/13	298.88KB	Share
CGS	Appendix 3B		02/12/13	1.42MB	Share
CGS	Change in substantial holding		28/11/13	1.29MB	Share
CGS	Change in substantial holding		27/11/13	657.69KB	Share
CGS	Change in substantial holding		27/11/13	131.24KB	Share
CGS	Initial Director's Interest Notice		27/11/13	241.83KB	Share
CGS	Becoming a substantial holder		25/11/13	539.66KB	Share
CGS	Appendix 3B (Placement)		22/11/13	2.71MB	Share
CGS	Cleansing Notice (Placement)		22/11/13	368.03KB	Share
CGS	Change of Director's Interest Notice		22/11/13	296.75KB	Share
CGS	Change of Director's Interest Notice		22/11/13	307.44KB	Share
CGS	Change of Director's Interest Notice		22/11/13	298.94KB	Share
CGS	Appendix 3B		22/11/13	1.47MB	Share
CGS	Appendix 3B		19/11/13	2.87MB	Share
CGS	Cleansing Notice		19/11/13	200.34KB	Share
CGS	Fully Underwritten Non-Renounceable Rights Issue / Placement	PRICE SENSITIVE	19/11/13	435.48KB	Share
CGS	Business Update and First Half Financial Guidance	PRICE SENSITIVE	19/11/13	369.74KB	Share
CGS	Trading Halt	PRICE SENSITIVE	18/11/13	400.82KB	Share
CGS	Appendix 3B		15/11/13	1.48MB	Share
CGS	Change of Director's Interest Notice		08/11/13	295KB	Share
CGS	Change of Director's Interest Notice		08/11/13	294.53KB	Share
CGS	Change of Director's Interest Notice		08/11/13	295.54KB	Share
CGS	Change of Director's Interest Notice		08/11/13	298.02KB	Share
CGS	Change of Director's Interest Notice		08/11/13	305.94KB	Share
CGS	Appendix 3B		08/11/13	1.43MB	Share
CGS	Results of Meeting		24/10/13	98.24KB	Share
CGS	AGM Presentation slides	PRICE SENSITIVE	23/10/13	1.01MB	Share
CGS	30 Sep 2013 Business Update and Appendix 4C	PRICE SENSITIVE	23/10/13	1.35MB	Share
CGS	Chairman's Address to Shareholders		23/10/13	123.94KB	Share
CGS	Merck releases new data on effectiveness of Cognigram	PRICE SENSITIVE	08/10/13	325.79KB	Share
CGS	Growing recognition of Cogstate test as a cognitive tool	PRICE SENSITIVE	26/09/13	277.45KB	Share
CGS	Notice of Annual General Meeting		19/09/13	3.53MB	Share
CGS	Appendix 3B		19/09/13	306.92KB	Share
CGS	Change of Director's Interest Notice		13/09/13	305.85KB	Share
CGS	Annual Report to shareholders		05/09/13	13.59MB	Share
CGS	Cogstate Investor Briefing - September 2013		04/09/13	637.75KB	Share
CGS	Change of Director's Interest Notice		02/09/13	306.82KB	Share
CGS	Appendix 3B		02/09/13	382.76KB	Share
CGS	Business Update		21/08/13	271.52KB	Share
CGS	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	21/08/13	3.66MB	Share
CGS	Notice of Investor Conference Call		15/08/13	246.71KB	Share
CGS	Appendix 3B		08/08/13	140.89KB	Share
CGS	Appendix 3B		05/08/13	143.41KB	Share
CGS	Quarterly Business Update and Cashflow - 30 June 2013	PRICE SENSITIVE	29/07/13	267.71KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/13	385.07KB	Share
CGS	Appendix 3B		26/07/13	141.38KB	Share
CGS	Australian research on Alzheimer's disease, BRR Webcast		17/07/13	250.3KB	Share
CGS	Australian research sheds new light on Alzheimer's disease		15/07/13	333.9KB	Share
CGS	Australian research sheds new light on Alzheimer's disease		15/07/13	270.61KB	Share
CGS	Appendix 3B		18/06/13	132.61KB	Share
CGS	Change of Director's Interest Notice		14/06/13	299.04KB	Share
CGS	Change of Director's Interest Notice		27/05/13	247.59KB	Share
CGS	Company Secretary Appointment		24/05/13	191.84KB	Share
CGS	Cogstate selected for Alzheimers disease preventation trial	PRICE SENSITIVE	23/05/13	216.3KB	Share
CGS	Appendix 3B		16/05/13	128.15KB	Share
CGS	Change of Director's Interest Notice		01/05/13	240.96KB	Share
CGS	Appendix 3B		01/05/13	132.11KB	Share

CGS Appendix 3B
09/09/14		1.57MB	Share
CGS Appendix 3B
01/09/14		1.61MB	Share
CGS Cogstate Test Provides Better Assessment than Observation
25/08/14	PRICE SENSITIVE	268.71KB	Share
CGS Appendix 4E and Preliminary Final Report
20/08/14	PRICE SENSITIVE	1.01MB	Share
CGS Contracts signed since 1 July 2014 hit $9 million
14/08/14	PRICE SENSITIVE	271.16KB	Share
CGS Appendix 3B
12/08/14		1.6MB	Share
CGS Cogstate signs $7.3 million sales contract
05/08/14	PRICE SENSITIVE	280.96KB	Share
CGS Appendix 4C - quarterly
22/07/14	PRICE SENSITIVE	1.58MB	Share
CGS Appendix 3B
18/07/14		1.58MB	Share
CGS Cogstate provides update on sales contracts
24/06/14	PRICE SENSITIVE	274.76KB	Share
CGS Appendix 3B
18/06/14		1.58MB	Share
CGS Cogstate signs first client to Precision Recruitment
12/06/14	PRICE SENSITIVE	267.7KB	Share
CGSInvestor Presentation
06/06/14		1.19MB	Share
CGSBusiness update and guidance on FY14 results
06/06/14	PRICE SENSITIVE	280.62KB	Share
CGSCogstate announces updated agreement with Merck Canada
02/06/14	PRICE SENSITIVE	438.11KB	Share
CGSAppendix 3B
07/05/14		1.59MB	Share
CGSAppendix 4C - quarterly
28/04/14	PRICE SENSITIVE	1.56MB	Share
CGSCompany Secretary Appointment/Resignation
28/04/14		282.41KB	Share
CGSCogstate technology chosen for major Phase III trial
24/03/14	PRICE SENSITIVE	363.19KB	Share
CGSChange of Director's Interest Notice
26/02/14		308.47KB	Share
CGSH1 FY14 Investor Presentation
19/02/14		1.3MB	Share
CGSBusiness Update - Significant growth in future revenue
18/02/14	PRICE SENSITIVE	286.33KB	Share
CGSAppendix 4D and Half-Year Financial Report
18/02/14	PRICE SENSITIVE	5.15MB	Share
CGSNotification of 2014 Half Year Results
12/02/14		247.97KB	Share
CGSCogstate Test to be used in large paediatric clinical trial
12/02/14	PRICE SENSITIVE	244.69KB	Share
CGSChange of Director's Interest Notice
29/01/14		298.1KB	Share
CGSAppendix 3B
29/01/14		1.76MB	Share
CGSAppendix 4C - quarterly
28/01/14	PRICE SENSITIVE	1.49MB	Share
CGSAppendix 3B
03/01/14		1.86MB	Share
CGSChange in substantial holding
24/12/13		656.03KB	Share
CGSChange in substantial holding
24/12/13		2.75MB	Share
CGSChange of Director's Interest Notice
24/12/13		309.23KB	Share
CGSChange of Director's Interest Notice
24/12/13		295.43KB	Share
CGSChange of Director's Interest Notice
24/12/13		297.51KB	Share
CGSChange of Director's Interest Notice
24/12/13		297.91KB	Share
CGSChange of Director's Interest Notice
24/12/13		298.64KB	Share
CGSCogstate Entitlement Offer - Notice of Under-subscriptions
23/12/13		307.01KB	Share
CGSCogstate completes A$8m Capital Raising
23/12/13		245.53KB	Share
CGSAppendix 3B
23/12/13		2.79MB	Share
CGSCogstate Awarded Tender
23/12/13	PRICE SENSITIVE	375.11KB	Share
CGSChange of Director's Interest Notice
17/12/13		307.1KB	Share
CGSAxon Sports Strategic Partnership with GSK Human Lab
03/12/13		406.75KB	Share
CGSRights Issue Offer Document
03/12/13	PRICE SENSITIVE	1.14MB	Share
CGSChange of Director's Interest Notice
02/12/13		298.88KB	Share
CGSAppendix 3B
02/12/13		1.42MB	Share
CGSChange in substantial holding
28/11/13		1.29MB	Share
CGSChange in substantial holding
27/11/13		657.69KB	Share
CGSChange in substantial holding
27/11/13		131.24KB	Share
CGSInitial Director's Interest Notice
27/11/13		241.83KB	Share
CGSBecoming a substantial holder
25/11/13		539.66KB	Share
CGSAppendix 3B (Placement)
22/11/13		2.71MB	Share
CGSCleansing Notice (Placement)
22/11/13		368.03KB	Share
CGSChange of Director's Interest Notice
22/11/13		296.75KB	Share
CGSChange of Director's Interest Notice
22/11/13		307.44KB	Share
CGSChange of Director's Interest Notice
22/11/13		298.94KB	Share
CGSAppendix 3B
22/11/13		1.47MB	Share
CGSAppendix 3B
19/11/13		2.87MB	Share
CGSCleansing Notice
19/11/13		200.34KB	Share
CGSFully Underwritten Non-Renounceable Rights Issue / Placement
19/11/13	PRICE SENSITIVE	435.48KB	Share
CGSBusiness Update and First Half Financial Guidance
19/11/13	PRICE SENSITIVE	369.74KB	Share
CGSTrading Halt
18/11/13	PRICE SENSITIVE	400.82KB	Share
CGSAppendix 3B
15/11/13		1.48MB	Share
CGSChange of Director's Interest Notice
08/11/13		295KB	Share
CGSChange of Director's Interest Notice
08/11/13		294.53KB	Share
CGSChange of Director's Interest Notice
08/11/13		295.54KB	Share
CGSChange of Director's Interest Notice
08/11/13		298.02KB	Share
CGSChange of Director's Interest Notice
08/11/13		305.94KB	Share
CGSAppendix 3B
08/11/13		1.43MB	Share
CGSResults of Meeting
24/10/13		98.24KB	Share
CGSAGM Presentation slides
23/10/13	PRICE SENSITIVE	1.01MB	Share
CGS30 Sep 2013 Business Update and Appendix 4C
23/10/13	PRICE SENSITIVE	1.35MB	Share
CGSChairman's Address to Shareholders
23/10/13		123.94KB	Share
CGSMerck releases new data on effectiveness of Cognigram
08/10/13	PRICE SENSITIVE	325.79KB	Share
CGSGrowing recognition of Cogstate test as a cognitive tool
26/09/13	PRICE SENSITIVE	277.45KB	Share
CGSNotice of Annual General Meeting
19/09/13		3.53MB	Share
CGSAppendix 3B
19/09/13		306.92KB	Share
CGSChange of Director's Interest Notice
13/09/13		305.85KB	Share
CGSAnnual Report to shareholders
05/09/13		13.59MB	Share
CGSCogstate Investor Briefing - September 2013
04/09/13		637.75KB	Share
CGSChange of Director's Interest Notice
02/09/13		306.82KB	Share
CGSAppendix 3B
02/09/13		382.76KB	Share
CGSBusiness Update
21/08/13		271.52KB	Share
CGSAppendix 4E and Preliminary Final Report
21/08/13	PRICE SENSITIVE	3.66MB	Share
CGSNotice of Investor Conference Call
15/08/13		246.71KB	Share
CGSAppendix 3B
08/08/13		140.89KB	Share
CGSAppendix 3B
05/08/13		143.41KB	Share
CGSQuarterly Business Update and Cashflow - 30 June 2013
29/07/13	PRICE SENSITIVE	267.71KB	Share
CGSAppendix 4C - quarterly
29/07/13	PRICE SENSITIVE	385.07KB	Share
CGSAppendix 3B
26/07/13		141.38KB	Share
CGSAustralian research on Alzheimer's disease, BRR Webcast
17/07/13		250.3KB	Share
CGSAustralian research sheds new light on Alzheimer's disease
15/07/13		333.9KB	Share
CGSAustralian research sheds new light on Alzheimer's disease
15/07/13		270.61KB	Share
CGSAppendix 3B
18/06/13		132.61KB	Share
CGSChange of Director's Interest Notice
14/06/13		299.04KB	Share
CGSChange of Director's Interest Notice
27/05/13		247.59KB	Share
CGSCompany Secretary Appointment
24/05/13		191.84KB	Share
CGSCogstate selected for Alzheimers disease preventation trial
23/05/13	PRICE SENSITIVE	216.3KB	Share
CGSAppendix 3B
16/05/13		128.15KB	Share
CGSChange of Director's Interest Notice
01/05/13		240.96KB	Share
CGSAppendix 3B
01/05/13		132.11KB	Share

REFRESH

First 7 8 9 10 11

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.02		Change 0.020(1.00%)		Mkt cap ! $345.8M

Open	High	Low	Value	Volume
$2.00	$2.07	$1.98	$509.1K	251.9K

Buyers (Bids)

No.	Vol.	Price($)
1	10000	$2.01

Sellers (Offers)

Price($)	Vol.	No.
$2.02	22222	1

View Market Depth

No.	Vol.	Price($)
1	10000	2.010
1	1000	2.000
1	5050	1.980
2	13257	1.950
1	5000	1.910

Price($)	Vol.	No.
2.020	22222	1
2.100	611	1
2.120	2000	1
2.190	3341	1
2.200	5900	2

Last trade - 16.10pm 19/09/2025 (20 minute delay)

CGS (ASX) Chart

COGSTATE LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available